Outlook on the Worldwide Prefilled Syringe Fill/Finish Services Industry to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringe Fill / Finish Services Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

This report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes. The study features an in-depth analysis of the key drivers and trends related to this evolving domain.

Among drug delivery devices, prefilled syringes represent one of the fastest growing primary packaging formats, which are also designed for dose administration. In fact, over the past ten years, there has been an evident increase in the development of parenteral drugs (especially with the introduction of several classes of biologics), which has resulted in an increased consumption of prefilled syringes, by approximately three fold. The sustained preference for such products can be attributed to the fact that prefilled syringes are safe and easy-to-use, and current variants are designed with provisions to reduce dosing errors, the risk of occlusions, extravasation and phlebitis.

Owing to the aforementioned benefits, several injectable drugs (such as Humira, Enbrel, Avastin, PREVNAR 13, ALPROLIX and Benefix), diluents and other products requiring parenteral administration, are packaged in prefilled syringes. In fact, over the past seven years, around 90 drugs have been approved in combination with prefilled syringes across different geographies, including the North America, Europe and Asia-Pacific. Moreover, several clinical-stage drugs are being evaluated in combination with prefilled syringes, across different phases of development.

The filling of sterile drugs into prefilled syringes (and other primary drug containers) is considered to be one of the most crucial steps in the pharmaceutical production process. Proper fill/finish operations, carried out under aseptic conditions, is a necessity for not only maintaining pharmacological efficacy and quality, but also ensuring end user safety. The prefilled syringe filling operation is considered complex as it requires close monitoring of both the syringe fill volume as well as the headspace between the liquid in the syringe and the bottom of the plunger.

Currently, over 100 companies are actively providing fill/finish services for prefilled syringes. In order to cope up with the current and future market demand, service providers are actively investing in expanding their existing infrastructure and capabilities; companies are also expanding their client reach through service agreements in the past few years. Given that around 55% of drug candidates in the global R&D pipeline are injectables, the opportunities for prefilled syringe developers / manufacturers and affiliated service providers is anticipated to continue to grow over the next decade. In addition, owing to the recent COVID-19 pandemic, an increase in the development initiatives for the vaccines is likely to be witnessed in the near future. This is expected to significantly raise the demand for prefilled syringes, providing an additional impetus to the overall fill/finish services market.

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE

5. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES

6. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES

7. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES

8. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS

8.1. Chapter Overview

8.2. Partnership Models

8.3 List of Partnerships and Collaborations

8.4. List of Expansions

9. CAPACITY ANALYSIS

9.1. Chapter Overview

9.2. Assumptions and Methodology

9.3. Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units)

9.4. Global, Prefilled Syringe Fill / Finish Capacity (by Volume)

10. DEMAND ANALYSIS

10.1. Chapter Overview

10.2. Assumptions and Methodology

10.3. Global Demand for Prefilled Syringe Fill / Finish Services

10.4. Analysis of Demand and Supply Dynamics

11. GEOGRAPHICAL ASSESSMENT OF DEMAND AND SUPPLY

11.1. Chapter Overview

11.2. Demand and Supply Assessment in North America

11.3. Demand and Supply Assessment in Europe

11.4. Demand and Supply Assessment in Asia-Pacific and Rest of the World

12. LIKELY PARTNER ANALYSIS

12.1. Chapter Overview

12.2. Methodology and Key Parameters

12.3. Likely Partner Analysis

13. MARKET SIZING AND OPPORTUNITY ANALYSIS

13.1. Chapter Overview

13.2. Forecast Methodology and Key Assumptions

13.3. Overall Prefilled Syringe Fill / Finish Services Market, 2020-2030

14. FUTURE GROWTH OPPORTUNITIES

14.1. Chapter Overview

14.2. Growing Injectable Drugs Pipeline

14.3. Increase in Outsourcing of Fill / Finish Activities

14.4. Rising Preference for Self-Medication

14.5. Increase in Popularity of Prefilled Syringes

14.6. Advances in Aseptic Fill / Finish Technologies

15. PREFILLED SYRINGE MANUFACTURERS

15.1. Chapter Overview

15.2. Prefilled Syringes: List of Available / Under Development Devices

15.3. Prefilled Syringes: List of Manufacturers

16. CONCLUDING REMARKS

16.1. Chapter Overview

16.2. Key Takeaways

17. INTERVIEW TRANSCRIPTS

Companies Mentioned

• AbbVie Contract Manufacturing
• Aguettant
• AJ Biologics
• Ajinomoto Bio-Pharma Services
• Akron Biotech
• Akums Drugs and Pharmaceuticals
• Alanza
• Alcami
• Alfasigma
• Alkermes
• AMRI
• APL
• Aristopharma
• Austrianova
• Automated Systems of Tacoma
• Axcellerate Pharma
• Bahrain Pharma
• Baxter
• Becton Dickinson
• Berkshire Sterile Manufacturing
• Beximco Pharma
• Bio Elpida
• Biocon
• BioConnection
• Biomedical Advanced Research and Development Authority
• BioPharma Solutions
• Biotech Vision Care
• BirgiMefar
• Boehringer Ingelheim BioXcellence
• Bryllan
• CARBOGEN AMCIS
• Catalent Biologics
• Cenexi
• Cerium Pharmaceuticals
• CinnaGen
• Ciron Drugs and Pharmaceutical
• Cobra Biologics
• Consort Medical
• Cook Pharmica
• And Many More Companies!

For more information about this report visit https://www.researchandmarkets.com/r/7qnae